
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $357.2M | $435.1M | $490.4M | $491.2M | $510.9M | |
Revenue Growth (YoY) | -3.47% | 21.84% | 12.7% | 0.16% | 4.01% | |
Cost of Revenues | $301.8M | $327.1M | $354.4M | $323.6M | $323.4M | |
Gross Profit | $55.4M | $108M | $136M | $167.6M | $187.5M | |
Gross Profit Margin | 15.51% | 24.83% | 27.74% | 34.12% | 36.7% | |
R&D Expenses | $60.1M | $59.1M | $64.7M | $68.6M | $73.2M | |
Selling, General & Admin | $100.2M | $98.4M | $126M | $122.5M | $145.9M | |
Other Inc / (Exp) | $3.4M | -$4.3M | $302K | $107K | -$104K | |
Operating Expenses | $160.3M | $159.1M | $192.9M | $192.5M | $222.4M | |
Operating Income | -$104.9M | -$51M | -$56.9M | -$24.9M | -$34.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$100.6M | -$55.4M | -$55.7M | -$20.9M | -$29.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $625K | $677K | $975K | $1.2M | $1.1M | |
Net Income to Company | -$101.3M | -$56M | -$56.6M | -$22M | -$30.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$101.3M | -$56M | -$56.6M | -$22M | -$30.5M | |
Basic EPS (Cont. Ops) | -$1.30 | -$0.68 | -$0.65 | -$0.24 | -$0.31 | |
Diluted EPS (Cont. Ops) | -$1.30 | -$0.68 | -$0.65 | -$0.24 | -$0.31 | |
Weighted Average Basic Share | $78.1M | $82.7M | $87.2M | $92.8M | $98.6M | |
Weighted Average Diluted Share | $78.1M | $82.7M | $87.2M | $92.8M | $98.6M | |
EBITDA | -$94.7M | -$45M | -$52.1M | -$20.2M | -$31.7M | |
EBIT | -$104.9M | -$51M | -$56.9M | -$24.9M | -$34.9M | |
Revenue (Reported) | $357.2M | $435.1M | $490.4M | $491.2M | $510.9M | |
Operating Income (Reported) | -$104.9M | -$51M | -$56.9M | -$24.9M | -$34.9M | |
Operating Income (Adjusted) | -$104.9M | -$51M | -$56.9M | -$24.9M | -$34.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $82.6M | $124.8M | $111M | $124.2M | $119.1M | |
Revenue Growth (YoY) | 26.14% | 51.11% | -11.02% | 11.89% | -4.13% | |
Cost of Revenues | $56.7M | $91.2M | $75.8M | $76.8M | $66.3M | |
Gross Profit | $25.8M | $33.6M | $35.2M | $47.4M | $52.7M | |
Gross Profit Margin | 31.26% | 26.91% | 31.73% | 38.15% | 44.28% | |
R&D Expenses | $14.8M | $16.4M | $17.8M | $20.8M | $16.2M | |
Selling, General & Admin | $22.4M | $25.8M | $31M | $36.7M | $38M | |
Other Inc / (Exp) | $855K | $411K | -$39K | -$25K | -$198K | |
Operating Expenses | $37.2M | $42.2M | $49.4M | $58M | $54.2M | |
Operating Income | -$11.4M | -$8.7M | -$14.1M | -$10.6M | -$1.5M | |
Net Interest Expenses | -- | $5K | -- | -- | -- | |
EBT. Incl. Unusual Items | -$10.5M | -$8.3M | -$13.5M | -$9.2M | -$333K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $180K | $213K | $792K | $395K | $502K | |
Net Income to Company | -$10.7M | -$8.5M | -$14.2M | -$9.6M | -$835K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$10.7M | -$8.5M | -$14.2M | -$9.6M | -$835K | |
Basic EPS (Cont. Ops) | -$0.13 | -$0.10 | -$0.16 | -$0.10 | -$0.01 | |
Diluted EPS (Cont. Ops) | -$0.13 | -$0.10 | -$0.16 | -$0.10 | -$0.01 | |
Weighted Average Basic Share | $80.4M | $85.2M | $89.7M | $96.3M | $102.2M | |
Weighted Average Diluted Share | $80.4M | $85.2M | $89.7M | $96.3M | $102.2M | |
EBITDA | -$9.9M | -$7.4M | -$13M | -$9.7M | -$622K | |
EBIT | -$11.4M | -$8.7M | -$14.1M | -$10.6M | -$1.5M | |
Revenue (Reported) | $82.6M | $124.8M | $111M | $124.2M | $119.1M | |
Operating Income (Reported) | -$11.4M | -$8.7M | -$14.1M | -$10.6M | -$1.5M | |
Operating Income (Adjusted) | -$11.4M | -$8.7M | -$14.1M | -$10.6M | -$1.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $374.3M | $477.3M | $476.7M | $504.4M | $505.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $297M | $361.5M | $339M | $324.6M | $312.9M | |
Gross Profit | $77.2M | $115.8M | $137.7M | $179.7M | $192.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $59.7M | $60.7M | $66.1M | $71.7M | $68.6M | |
Selling, General & Admin | $92.8M | $101.8M | $131.2M | $128.3M | $147.1M | |
Other Inc / (Exp) | $2.9M | -$4.8M | -$148K | $121K | -$277K | |
Operating Expenses | $152.4M | $164.1M | $200M | $201.1M | $218.6M | |
Operating Income | -$75.2M | -$48.3M | -$62.3M | -$21.4M | -$25.7M | |
Net Interest Expenses | -- | $18K | -- | -- | -- | |
EBT. Incl. Unusual Items | -$72M | -$53.1M | -$60.8M | -$16.7M | -$20.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $660K | $710K | $1.6M | $778K | $1.2M | |
Net Income to Company | -$72.6M | -$53.8M | -$62.4M | -$17.4M | -$21.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$72.6M | -$53.8M | -$62.4M | -$17.4M | -$21.7M | |
Basic EPS (Cont. Ops) | -$0.92 | -$0.64 | -$0.70 | -$0.18 | -$0.22 | |
Diluted EPS (Cont. Ops) | -$0.92 | -$0.64 | -$0.70 | -$0.18 | -$0.22 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$66.2M | -$42.5M | -$57.7M | -$17M | -$22.6M | |
EBIT | -$75.2M | -$48.3M | -$62.3M | -$21.4M | -$25.7M | |
Revenue (Reported) | $374.3M | $477.3M | $476.7M | $504.4M | $505.8M | |
Operating Income (Reported) | -$75.2M | -$48.3M | -$62.3M | -$21.4M | -$25.7M | |
Operating Income (Adjusted) | -$75.2M | -$48.3M | -$62.3M | -$21.4M | -$25.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $82.6M | $124.8M | $111M | $124.2M | $119.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $56.7M | $91.2M | $75.8M | $76.8M | $66.3M | |
Gross Profit | $25.8M | $33.6M | $35.2M | $47.4M | $52.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $14.8M | $16.4M | $17.8M | $20.8M | $16.2M | |
Selling, General & Admin | $22.4M | $25.8M | $31M | $36.7M | $38M | |
Other Inc / (Exp) | $855K | $411K | -$39K | -$25K | -$198K | |
Operating Expenses | $37.2M | $42.2M | $49.4M | $58M | $54.2M | |
Operating Income | -$11.4M | -$8.7M | -$14.1M | -$10.6M | -$1.5M | |
Net Interest Expenses | -- | $5K | -- | -- | -- | |
EBT. Incl. Unusual Items | -$10.5M | -$8.3M | -$13.5M | -$9.2M | -$333K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $180K | $213K | $792K | $395K | $502K | |
Net Income to Company | -$10.7M | -$8.5M | -$14.2M | -$9.6M | -$835K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$10.7M | -$8.5M | -$14.2M | -$9.6M | -$835K | |
Basic EPS (Cont. Ops) | -$0.13 | -$0.10 | -$0.16 | -$0.10 | -$0.01 | |
Diluted EPS (Cont. Ops) | -$0.13 | -$0.10 | -$0.16 | -$0.10 | -$0.01 | |
Weighted Average Basic Share | $80.4M | $85.2M | $89.7M | $96.3M | $102.2M | |
Weighted Average Diluted Share | $80.4M | $85.2M | $89.7M | $96.3M | $102.2M | |
EBITDA | -$9.9M | -$7.4M | -$13M | -$9.7M | -$622K | |
EBIT | -$11.4M | -$8.7M | -$14.1M | -$10.6M | -$1.5M | |
Revenue (Reported) | $82.6M | $124.8M | $111M | $124.2M | $119.1M | |
Operating Income (Reported) | -$11.4M | -$8.7M | -$14.1M | -$10.6M | -$1.5M | |
Operating Income (Adjusted) | -$11.4M | -$8.7M | -$14.1M | -$10.6M | -$1.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $186.1M | $175.7M | $84M | $56.5M | $82M | |
Short Term Investments | $20M | -- | $29.7M | $80M | $69.4M | |
Accounts Receivable, Net | $77.6M | $79.6M | $66M | $65.4M | $57.3M | |
Inventory | $64.7M | $38.4M | $46.6M | $38.4M | $40.6M | |
Prepaid Expenses | $8.1M | -- | -- | -- | -- | |
Other Current Assets | -- | $9.9M | $6.5M | $10.3M | $13.2M | |
Total Current Assets | $356.5M | $303.6M | $232.8M | $250.5M | $262.6M | |
Property Plant And Equipment | $39.8M | $24.4M | $20.1M | $16.2M | $20.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $11M | $11M | $11M | $11M | $11M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $5.2M | $6.9M | $8.2M | $7.8M | $4.3M | |
Total Assets | $414M | $347.5M | $272.2M | $285.5M | $298.4M | |
Accounts Payable | $62.2M | $84.1M | $52.1M | $55.2M | $63.8M | |
Accrued Expenses | $102.3M | $80.4M | $83.3M | $74.9M | $72.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $4.4M | $4.6M | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $237.3M | $210.9M | $162.3M | $161.5M | $176.8M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $280.2M | $234.8M | $184.5M | $182.3M | $197.5M | |
Common Stock | $79K | $84K | $89K | $95K | $101K | |
Other Common Equity Adj | $3K | -- | -$107K | $320K | $34K | |
Common Equity | $133.8M | $112.7M | $87.7M | $103.3M | $100.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $133.8M | $112.7M | $87.7M | $103.3M | $100.9M | |
Total Liabilities and Equity | $414M | $347.5M | $272.2M | $285.5M | $298.4M | |
Cash and Short Terms | $206.1M | $175.7M | $113.7M | $136.5M | $151.5M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $172.1M | $101M | $67M | $62.1M | $84M | |
Short Term Investments | $5M | $44.6M | $51.7M | $80.8M | $69.1M | |
Accounts Receivable, Net | $51.1M | $78.1M | $52.8M | $56.5M | $46.1M | |
Inventory | $56M | $37M | $39.9M | $44.7M | $34.6M | |
Prepaid Expenses | $7.7M | $9M | -- | -- | -- | |
Other Current Assets | -- | -- | $7.4M | $11.9M | $12.6M | |
Total Current Assets | $291.9M | $269.6M | $218.8M | $255.9M | $246.3M | |
Property Plant And Equipment | $37.5M | $24.1M | $19M | $15M | $22M | |
Long-Term Investments | -- | -- | -- | -- | $12.5M | |
Goodwill | $11M | $11M | $11M | $11M | $11M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $5.2M | $5.3M | $6.9M | $7.8M | $4.7M | |
Total Assets | $347.2M | $311.8M | $257.1M | $289.8M | $296.6M | |
Accounts Payable | $27.1M | $68.3M | $46M | $69.9M | $49.2M | |
Accrued Expenses | $81.3M | $75.5M | $67.2M | $63.9M | $68.2M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $4.4M | $4.5M | $3.9M | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $179.4M | $176.5M | $149.4M | $170.4M | $173.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $210.9M | $199.8M | $170.8M | $189.8M | $193.2M | |
Common Stock | $81K | $86K | $91K | $97K | $103K | |
Other Common Equity Adj | -- | -$46K | $21K | $280K | $5K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $136.3M | $112M | $86.3M | $99.9M | $103.4M | |
Total Liabilities and Equity | $347.2M | $311.8M | $257.1M | $289.8M | $296.6M | |
Cash and Short Terms | $177.1M | $145.5M | $118.7M | $142.9M | $153.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$101.3M | -$56M | -$56.6M | -$22M | -$30.5M | |
Depreciation & Amoritzation | $10.2M | $6M | $4.8M | $4.7M | $3.2M | |
Stock-Based Compensation | $35.2M | $38M | $48.5M | $47.9M | $68.7M | |
Change in Accounts Receivable | $49.8M | -$1.7M | $13.5M | $690K | $8.2M | |
Change in Inventories | $2.9M | $29.3M | -$7.9M | $7.8M | -$4.5M | |
Cash From Operations | -$46.5M | -$23.2M | -$46M | $38.3M | $51.3M | |
Capital Expenditures | $3.9M | $2.3M | $2M | $2.8M | $2.7M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$4M | $17.7M | -$31.8M | -$50.7M | $10.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -$4.4M | |
Other Financing Activities | -$4.8M | -$13.2M | -$18.2M | -$23.6M | -$44.7M | |
Cash From Financing | -$23K | -$5M | -$13.9M | -$15.1M | -$40.8M | |
Beginning Cash (CF) | $240.8M | $190.3M | $179.9M | $88.2M | $60.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$50.5M | -$10.4M | -$91.7M | -$27.5M | $21.4M | |
Ending Cash (CF) | $190.3M | $179.9M | $88.2M | $60.7M | $82M | |
Levered Free Cash Flow | -$50.4M | -$25.5M | -$48M | $35.5M | $48.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$10.7M | -$8.5M | -$14.2M | -$9.6M | -$835K | |
Depreciation & Amoritzation | $1.5M | $1.3M | $1.1M | $903K | $829K | |
Stock-Based Compensation | $8.3M | $9.6M | $14.6M | $18.6M | $17M | |
Change in Accounts Receivable | $26.5M | $1.5M | $13.2M | $9M | $11.3M | |
Change in Inventories | $9.3M | $1.5M | $6.3M | -$6.3M | $5.6M | |
Cash From Operations | -$30.2M | -$24.6M | $10.3M | $19.8M | $30.9M | |
Capital Expenditures | $803K | $298K | $923K | $356K | $2.8M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $14.2M | -$44.9M | -$22.7M | -$440K | -$14.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -$15.2M | |
Other Financing Activities | -$4.2M | -$6.7M | -$4.7M | -$14.4M | -- | |
Cash From Financing | $2M | -$5.3M | -$4.7M | -$13.8M | -$14.6M | |
Beginning Cash (CF) | $190.3M | $179.9M | $88.2M | $60.7M | $82M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$14M | -$74.8M | -$17M | $5.6M | $2M | |
Ending Cash (CF) | $176.3M | $105.1M | $71.1M | $66.2M | $84M | |
Levered Free Cash Flow | -$31M | -$24.9M | $9.4M | $19.5M | $28.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$72.6M | -$53.8M | -$62.4M | -$17.4M | -$21.7M | |
Depreciation & Amoritzation | $9M | $5.7M | $4.6M | $4.4M | $3.1M | |
Stock-Based Compensation | $30.8M | $39.3M | $53.5M | $51.9M | $67.1M | |
Change in Accounts Receivable | $10.6M | -$26.8M | $25.2M | -$3.5M | $10.5M | |
Change in Inventories | $6M | $21.5M | -$3M | -$4.8M | $7.4M | |
Cash From Operations | -$27.8M | -$17.6M | -$11.1M | $47.8M | $62.4M | |
Capital Expenditures | $3.6M | $1.8M | $2.6M | $2.3M | $5.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $21.4M | -$41.4M | -$9.5M | -$28.5M | -$3.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$6.9M | -$15.7M | -$16.2M | -$33.3M | -- | |
Cash From Financing | $2.1M | -$12.2M | -$13.4M | -$24.2M | -$41.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$4.3M | -$71.2M | -$33.9M | -$4.9M | $17.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$31.4M | -$19.3M | -$13.7M | $45.5M | $57.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$10.7M | -$8.5M | -$14.2M | -$9.6M | -$835K | |
Depreciation & Amoritzation | $1.5M | $1.3M | $1.1M | $903K | $829K | |
Stock-Based Compensation | $8.3M | $9.6M | $14.6M | $18.6M | $17M | |
Change in Accounts Receivable | $26.5M | $1.5M | $13.2M | $9M | $11.3M | |
Change in Inventories | $9.3M | $1.5M | $6.3M | -$6.3M | $5.6M | |
Cash From Operations | -$30.2M | -$24.6M | $10.3M | $19.8M | $30.9M | |
Capital Expenditures | $803K | $298K | $923K | $356K | $2.8M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $14.2M | -$44.9M | -$22.7M | -$440K | -$14.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -$15.2M | |
Other Financing Activities | -$4.2M | -$6.7M | -$4.7M | -$14.4M | -- | |
Cash From Financing | $2M | -$5.3M | -$4.7M | -$13.8M | -$14.6M | |
Beginning Cash (CF) | $190.3M | $179.9M | $88.2M | $60.7M | $82M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$14M | -$74.8M | -$17M | $5.6M | $2M | |
Ending Cash (CF) | $176.3M | $105.1M | $71.1M | $66.2M | $84M | |
Levered Free Cash Flow | -$31M | -$24.9M | $9.4M | $19.5M | $28.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.